Prevest Denpro [PREVEST] vs Dr Agarwal's Health [AGARWALEYE] Detailed Stock Comparison

Prevest Denpro Ltd.

BSE
Loading...

Dr Agarwal's Health Care Ltd

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Prevest Denpro Ltd. wins in 12 metrics, Dr Agarwal's Health Care Ltd wins in 5 metrics, with 1 ties. Prevest Denpro Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Prevest Denpro Ltd. Dr Agarwal's Health Care Ltd Better
P/E Ratio (TTM) 27.33 109.80 Prevest Denpro Ltd.
Price-to-Book Ratio 4.69 7.17 Prevest Denpro Ltd.
Debt-to-Equity Ratio 0.00 48.68 Tie
PEG Ratio 6.44 77.92 Prevest Denpro Ltd.
EV/EBITDA 18.92 30.74 Prevest Denpro Ltd.
Profit Margin (TTM) 27.78% 6.38% Prevest Denpro Ltd.
Operating Margin (TTM) 28.67% 14.22% Prevest Denpro Ltd.
EBITDA Margin (TTM) 28.67% 14.22% Prevest Denpro Ltd.
Return on Equity 17.20% 4.33% Prevest Denpro Ltd.
Return on Assets (TTM) 16.13% 2.27% Prevest Denpro Ltd.
Free Cash Flow (TTM) $128.49M $394.30M Dr Agarwal's Health Care Ltd
Dividend Yield 0.17% N/A N/A
1-Year Return -18.89% 43.01% Dr Agarwal's Health Care Ltd
Price-to-Sales Ratio (TTM) 7.59 7.03 Dr Agarwal's Health Care Ltd
Enterprise Value $4.68B $144.88B Dr Agarwal's Health Care Ltd
EV/Revenue Ratio 6.57 7.33 Prevest Denpro Ltd.
Gross Profit Margin (TTM) 79.68% 62.87% Prevest Denpro Ltd.
Revenue per Share (TTM) $59 $63 Dr Agarwal's Health Care Ltd
Earnings per Share (Diluted) $16.51 $3.99 Prevest Denpro Ltd.
Beta (Stock Volatility) 0.56 N/A N/A

Prevest Denpro Ltd. vs Dr Agarwal's Health Care Ltd Stock Performance Analysis

Loading Price Chart...

PREVEST
AGARWALEYE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Prevest Denpro Ltd.-0.80%0.40%-9.74%-10.99%-16.00%-17.27%
Dr Agarwal's Health Care Ltd-2.58%-0.64%5.30%6.33%-8.21%-4.74%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Prevest Denpro Ltd.-18.89%-9.41%368.10%368.10%368.10%368.10%
Dr Agarwal's Health Care Ltd43.01%20.41%20.41%20.41%20.41%20.41%

Performance & Financial Health Analysis: Prevest Denpro Ltd. vs Dr Agarwal's Health Care Ltd

MetricPREVESTAGARWALEYE
Market Information
Market Cap i₹5.42B₹138.86B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i15,10098,862
90 Day Avg. Volume i32,133169,210
Last Close₹385.00₹464.25
52 Week Range₹318.15 - ₹622.05₹332.50 - ₹568.00
% from 52W High-38.11%-18.27%
All-Time High₹686.00 (Jan 13, 2025)₹568.00 (Oct 16, 2025)
% from All-Time High-43.88%-18.27%
Growth Metrics
Quarterly Revenue Growth0.24%0.23%
Quarterly Earnings Growth0.04%0.51%
Financial Health
Profit Margin (TTM) i0.28%0.06%
Operating Margin (TTM) i0.29%0.14%
Return on Equity (TTM) i0.17%0.04%
Debt to Equity (MRQ) i0.0048.68
Cash & Liquidity
Book Value per Share (MRQ)₹96.29₹61.13
Cash per Share (MRQ)₹61.36₹12.58
Operating Cash Flow (TTM) i₹185.37M₹1.43B
Levered Free Cash Flow (TTM) i₹181.55M₹834.60M
Dividends
Last 12-Month Dividend Yield i0.17%N/A
Last 12-Month Dividend i₹1.00N/A

Valuation & Enterprise Metrics Analysis: Prevest Denpro Ltd. vs Dr Agarwal's Health Care Ltd

MetricPREVEST (Apr 26, 2026)AGARWALEYE (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i27.33109.80
Forward P/E iN/A77.92
PEG Ratio i6.4477.92
Price to Sales (TTM) i7.597.03
Price to Book (MRQ) i4.697.17
Market Capitalization
Market Capitalization i₹5.42B₹138.86B
Enterprise Value i₹4.68B₹144.88B
Enterprise Value Metrics
Enterprise to Revenue i6.577.33
Enterprise to EBITDA i18.9230.74
Risk & Other Metrics
Beta i0.56N/A
Book Value per Share (MRQ) i₹96.29₹61.13

Financial Statements Comparison: Prevest Denpro Ltd. vs Dr Agarwal's Health Care Ltd

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPREVEST (2025)AGARWALEYE (2025)
Revenue/Sales i620.76M17.05B
Cost of Goods Sold i122.51M9.36B
COGS % of Revenue i19.7%54.9%
Gross Profit i498.25M7.69B
Gross Margin i80.3%45.1%
Research & Development iN/AN/A
Operating Income (EBIT) i205.13M2.49B
Operating Margin i33.0%14.6%
EBITDA i262.26M4.91B
EBITDA Margin i42.2%28.8%
Pre-Tax Income i242.50M1.60B
Pre-Tax Income % of Revenue i39.1%9.4%
Income Tax i60.95M495.10M
Income Tax % of Revenue i9.8%2.9%
Net Income (Profit) i181.55M1.10B
Profit Margin i29.2%6.5%

Balance Sheet & Liquidity Metrics

MetricPREVEST (2025)AGARWALEYE (2025)
Cash & Equivalents i608.98M1.04B
Total Current Assets i857.15M7.94B
Total Current Assets % of Revenue i138.1%46.6%
Total Current Liabilities i59.62M4.78B
Total Current Liabilities % of Revenue i9.6%28.0%
Long-Term Debt i08.08B
Long-Term Debt % of Revenue i0.0%47.4%
Total Shareholders Equity i1.06B19.27B
Retained Earnings i733.61M-1.85B
Retained Earnings % of Revenue i118.2%-10.9%
Property, Plant & Equipment i13.99M6.60B

Cash Flow Statement Comparison

MetricPREVEST (2025)AGARWALEYE (2025)
Operating Cash Flow i185.37M1.43B
Operating Cash Flow % of Revenue i29.9%8.4%
Capital Expenditures i-19.68M5.30M
Free Cash Flow i128.49M394.30M
FCF Margin i20.7%2.3%
Debt Repayment iN/A-2.03B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPREVESTAGARWALEYE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.00M316.96M
Float Shares i2.17M60.08M
% Held by Insiders i79.09%75.49%
% Held by Institutions i0.00%16.46%
% Held by Public i20.91%8.05%

Dividend Analysis & Yield Comparison: Prevest Denpro Ltd. vs Dr Agarwal's Health Care Ltd

MetricPREVESTAGARWALEYE
Last 12-Month Dividend i₹1.00N/A
Last 12-Month Dividend Yield i0.17%N/A
3-Year Avg Annual Dividend i₹0.33N/A
3-Year Avg Dividend Yield i0.17%N/A
3-Year Total Dividends i₹1.00N/A
Ex-Dividend DateSep 03, 2025N/A